Caribou Biosciences, Inc. (CRBU) vs TuHURA Biosciences, Inc. (HURA)

Caribou Biosciences, Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and TuHURA Biosciences, Inc. are of similar size ($134.0M and $133.8M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −1,030.4%) and the lower return on invested capital (−74.2% vs 0.00%). Across the 14 metrics below, Caribou Biosciences, Inc. leads on 7 and TuHURA Biosciences, Inc. on 7.

Valuation

Metric CRBU HURA Biotechnology median
P/E n/m n/m 7.88
P/S 12.58 n/m 11.47
P/B 1.29 7.37 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.39 n/m 10.73
Earnings yield (86.40%) (25.71%) (28.84%)
Free cash flow yield (105.20%) (22.29%) (23.03%)

Profitability

Metric CRBU HURA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,090.90%) 0.00% 0.00%
Net margin (1,030.42%) 0.00% 0.00%
Free cash flow margin (1,323.30%) 0.00% 0.00%
Return on equity (78.27%) (163.84%) (57.72%)
Return on assets (56.87%) (92.31%) (49.22%)
Return on invested capital 0.00% (74.20%) 0.00%

Growth

Metric CRBU HURA Biotechnology median
Revenue growth (TTM) 10.02% — 5.64%
EPS growth (last fiscal year) 3.64% 47.93% —
Revenue growth, 5-year CAGR (2.03%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU HURA Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 6.49 0.18 4.73
Net debt to EBITDA 0.96 0.12 0.96

Dividend

Metric CRBU HURA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRBU HURA Biotechnology median
Market cap 134.01m 133.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack